会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 2. 发明申请
    • Protein Expression Profile Database
    • 蛋白质表达谱数据库
    • US20100137151A1
    • 2010-06-03
    • US12621652
    • 2009-11-19
    • Andrew EmiliGerard Cagney
    • Andrew EmiliGerard Cagney
    • C40B30/02
    • G01N33/6818G16B15/00G16B30/00
    • This invention describes the use of peptide profiling to identify, characterize, and classify biological samples. In complex samples, many thousands of different peptides will be present at varying concentrations. The invention uses liquid chromatography and similar methods to separate peptides, which are then identified and quantified using mass spectrometry. By identification it is meant that the correct sequence of the peptide is established through comparisons with genome sequence databases, since the majority of peptides and proteins are unannotated and have no ascribed name or function. Quantification means an estimate of the absolute or relative abundance of the peptide species using mass spectrometry and related techniques including, but not limited to, pre- or post-experimental stable or unstable isotope incorporation, molecular mass tagging, is differential mass tagging, and amino acid analysis.
    • 本发明描述了肽分析的用途来鉴定,表征和分类生物样品。 在复杂样品中,将以不同的浓度存在数千种不同的肽。 本发明使用液相色谱和类似方法分离肽,然后使用质谱鉴定和定量。 通过鉴定,这意味着通过与基因组序列数据库进行比较来建立肽的正确序列,因为大多数肽和蛋白质是未注释的,并且没有归属的名称或功能。 定量是指使用质谱法和相关技术估计肽种类的绝对或相对丰度,包括但不限于实验前或实验后稳定或不稳定的同位素掺入,分子量标记,差异质量标记和氨基 酸分析。
    • 4. 发明申请
    • Protein expression profile database
    • 蛋白质表达谱数据库
    • US20050048564A1
    • 2005-03-03
    • US10479270
    • 2002-05-30
    • Andrew EmiliGerard Cagney
    • Andrew EmiliGerard Cagney
    • G01N33/68G06F19/16G06F19/22G01N33/53
    • G01N33/6818G16B15/00G16B30/00
    • This invention describes the use of peptide profiling to identify, characterize, and classify biological samples. In complex samples, many thousands of different peptides will be present at varying concentrations. The invention uses liquid chromatography and similar methods to separate peptides, which are then identified and quantified using mass spectrometry. By identification it is meant that the correct sequence of the peptide is established through comparisons with genome sequence databases, since the majority of peptides and proteins are unannotated and have no ascribed name or function. Quantification means an estimate of the absolute or relative abundance of the peptide species using mass spectrometry and related techniques including, but not limited to, pre- or post-experimental stable or unstable isotope incorporation, molecular mass tagging, differential mass tagging, and amino acid analysis.
    • 本发明描述了肽分析的用途来鉴定,表征和分类生物样品。 在复杂样品中,将以不同的浓度存在数千种不同的肽。 本发明使用液相色谱和类似方法分离肽,然后使用质谱鉴定和定量。 通过鉴定,这意味着通过与基因组序列数据库进行比较来建立肽的正确序列,因为大多数肽和蛋白质是未注释的,并且没有归属的名称或功能。 定量是指使用质谱法和相关技术估计肽种类的绝对或相对丰度,包括但不限于实验前或实验后稳定或不稳定的同位素掺入,分子量标记,差异质量标签和氨基酸 分析。